Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
22.64
+0.57 (2.56%)
Dec 20, 2024, 4:00 PM EST - Market closed
Neurogene Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Neurogene stock have an average target of 60.8, with a low estimate of 45 and a high estimate of 72. The average target predicts an increase of 168.55% from the current stock price of 22.64.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Neurogene stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +142.93% | Nov 25, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $60 → $45 | Buy | Maintains | $60 → $45 | +98.76% | Nov 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $55 | Strong Buy | Reiterates | $55 | +142.93% | Nov 19, 2024 |
| Stifel | Stifel | Strong Buy Maintains $44 → $60 | Strong Buy | Maintains | $44 → $60 | +165.02% | Nov 12, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $65 → $60 | Buy | Maintains | $65 → $60 | +165.02% | Nov 12, 2024 |
Financial Forecast
Revenue This Year
939.25K
Revenue Next Year
n/a
from 939.25K
EPS This Year
-4.43
from 2.93
EPS Next Year
-4.42
from -4.43
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.1M | n/a | n/a | |||
| Avg | 939,247 | n/a | n/a | |||
| Low | 882,000 | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.87 | -3.35 | -4.91 |
| Avg | -4.43 | -4.42 | -5.69 |
| Low | -4.51 | -5.15 | -6.53 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.